AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
X-ray-induced thermally stimulated luminescence of cerium-doped gadoliniumoxyorthosilicate
Authors: Cooke, DW Bennett, BL McClellan, KJ Roper, JM
Citation: Dw. Cooke et al., X-ray-induced thermally stimulated luminescence of cerium-doped gadoliniumoxyorthosilicate, RADIAT MEAS, 33(4), 2001, pp. 403-408
Indobufen - An updated review of its use in the management of atherothrombosis
Authors: Bhana, N McClellan, KJ
Citation: N. Bhana et Kj. Mcclellan, Indobufen - An updated review of its use in the management of atherothrombosis, DRUG AGING, 18(5), 2001, pp. 369-388
Room temperature single crystal elastic constants of boron carbide
Authors: McClellan, KJ Chu, F Roper, JM Shindo, I
Citation: Kj. Mcclellan et al., Room temperature single crystal elastic constants of boron carbide, J MATER SCI, 36(14), 2001, pp. 3403-3407
Losartan - A review of its use, with special focus on elderly patients
Authors: Simpson, KL McClellan, KJ
Citation: Kl. Simpson et Kj. Mcclellan, Losartan - A review of its use, with special focus on elderly patients, DRUG AGING, 16(3), 2000, pp. 227-250
Electron-lattice coupling parameters and oscillator strengths of cerium-doped lutetium oxyorthosilicate
Authors: Cooke, DW Bennett, BL McClellan, KJ Roper, JM Whittaker, MT Portis, AM
Citation: Dw. Cooke et al., Electron-lattice coupling parameters and oscillator strengths of cerium-doped lutetium oxyorthosilicate, PHYS REV B, 61(18), 2000, pp. 11973-11978
Radiation tolerance of complex oxides
Authors: Sickafus, KE Minervini, L Grimes, RW Valdez, JA Ishimaru, M Li, F McClellan, KJ Hartmann, T
Citation: Ke. Sickafus et al., Radiation tolerance of complex oxides, SCIENCE, 289(5480), 2000, pp. 748-751
Similarities in glow peak positions and kinetics parameters of oxyorthosilicates: evidence for unique intrinsic trapping sites
Authors: Cooke, DW Bennett, BL McClellan, KJ Roper, JM Whittaker, MT
Citation: Dw. Cooke et al., Similarities in glow peak positions and kinetics parameters of oxyorthosilicates: evidence for unique intrinsic trapping sites, J LUMINESC, 92(1-2), 2000, pp. 83-89
Crystal growth and optical characterization of cerium-doped Lu1.8Y0.2SiO5
Authors: Cooke, DW McClellan, KJ Bennett, BL Roper, JM Whittaker, MT Muenchausen, RE Sze, RC
Citation: Dw. Cooke et al., Crystal growth and optical characterization of cerium-doped Lu1.8Y0.2SiO5, J APPL PHYS, 88(12), 2000, pp. 7360-7362
Oscillator strengths, Huang-Rhys parameters, and vibrational quantum energies of cerium-doped gadolinium oxyorthosilicate
Authors: Cooke, DW Bennett, BL McClellan, KJ Roper, JM Whittaker, MT
Citation: Dw. Cooke et al., Oscillator strengths, Huang-Rhys parameters, and vibrational quantum energies of cerium-doped gadolinium oxyorthosilicate, J APPL PHYS, 87(11), 2000, pp. 7793-7797
Ropivacaine - An update of its use in regional anaesthesia
Authors: McClellan, KJ Faulds, D
Citation: Kj. Mcclellan et D. Faulds, Ropivacaine - An update of its use in regional anaesthesia, DRUGS, 60(5), 2000, pp. 1065-1093
Lercanidipine - A review of its use in hypertension
Authors: McClellan, KJ Jarvis, B
Citation: Kj. Mcclellan et B. Jarvis, Lercanidipine - A review of its use in hypertension, DRUGS, 60(5), 2000, pp. 1123-1140
Fluvoxamine - An updated review of its use in the management of adults with anxiety disorders
Authors: Figgitt, DP McClellan, KJ
Citation: Dp. Figgitt et Kj. Mcclellan, Fluvoxamine - An updated review of its use in the management of adults with anxiety disorders, DRUGS, 60(4), 2000, pp. 925-954
Tropisetron - An update of its use in the prevention of chemotherapy-induced nausea and vomiting
Authors: Simpson, K Spencer, CM McClellan, KJ
Citation: K. Simpson et al., Tropisetron - An update of its use in the prevention of chemotherapy-induced nausea and vomiting, DRUGS, 59(6), 2000, pp. 1297-1315
Dexmedetomidine
Authors: Bhana, N Goa, KL McClellan, KJ
Citation: N. Bhana et al., Dexmedetomidine, DRUGS, 59(2), 2000, pp. 263-268
Acamprosate - Pharmacoeconomic implications of therapy
Authors: Foster, RH McClellan, KJ
Citation: Rh. Foster et Kj. Mcclellan, Acamprosate - Pharmacoeconomic implications of therapy, PHARMACOECO, 16(6), 1999, pp. 743-755
Mo5Si3 single crystals: physical properties and mechanical behavior
Authors: Chu, F Thoma, DJ McClellan, KJ Peralta, P
Citation: F. Chu et al., Mo5Si3 single crystals: physical properties and mechanical behavior, MAT SCI E A, 261(1-2), 1999, pp. 44-52
Residual thermal stresses in MoSi2-Mo5Si3 in-situ composites
Authors: Peralta, P Dickerson, R Michael, JR McClellan, KJ Chu, F Mitchell, TE
Citation: P. Peralta et al., Residual thermal stresses in MoSi2-Mo5Si3 in-situ composites, MAT SCI E A, 261(1-2), 1999, pp. 261-269
Thermal expansion of single-crystalline La0.83Sr0.17MnO3: The importance of temperature-induced strain for the electrical resistivity
Authors: Neumeier, JJ Andres, K McClellan, KJ
Citation: Jj. Neumeier et al., Thermal expansion of single-crystalline La0.83Sr0.17MnO3: The importance of temperature-induced strain for the electrical resistivity, PHYS REV B, 59(3), 1999, pp. 1701-1705
Growth of oriented C11(b)MoSi(2) bicrystals using a modified Czochralski technique
Authors: Garrett, JD Peralta, P Michael, JR Chu, F McClellan, KJ Mitchell, TE
Citation: Jd. Garrett et al., Growth of oriented C11(b)MoSi(2) bicrystals using a modified Czochralski technique, J CRYST GR, 205(4), 1999, pp. 515-522
Intrinsic trapping sites in rare-earth and yttrium oxyorthosilicates
Authors: Cooke, DW Bennett, BL Muenchausen, RE McClellan, KJ Roper, JM Whittaker, MT
Citation: Dw. Cooke et al., Intrinsic trapping sites in rare-earth and yttrium oxyorthosilicates, J APPL PHYS, 86(9), 1999, pp. 5308-5310
Dofetilide - A review of its use in atrial fibrillation and atrial flutter
Authors: McClellan, KJ Markham, A
Citation: Kj. Mcclellan et A. Markham, Dofetilide - A review of its use in atrial fibrillation and atrial flutter, DRUGS, 58(6), 1999, pp. 1043-1059
Perindopril 2mg/indapamide 0.625mg - Fixed low-dose combination
Authors: McClellan, KJ Markham, A
Citation: Kj. Mcclellan et A. Markham, Perindopril 2mg/indapamide 0.625mg - Fixed low-dose combination, DRUGS, 58(2), 1999, pp. 297-302
Trimetazidine - A review of its use in stable angina pectoris and other coronary conditions
Authors: McClellan, KJ Plosker, GL
Citation: Kj. Mcclellan et Gl. Plosker, Trimetazidine - A review of its use in stable angina pectoris and other coronary conditions, DRUGS, 58(1), 1999, pp. 143-157
Terbinafine - An update of its use in superficial mycoses
Authors: McClellan, KJ Wiseman, LR Markham, A
Citation: Kj. Mcclellan et al., Terbinafine - An update of its use in superficial mycoses, DRUGS, 58(1), 1999, pp. 179-202
Valsartan hydrochlorothiazide
Authors: Langtry, HD McClellan, KJ
Citation: Hd. Langtry et Kj. Mcclellan, Valsartan hydrochlorothiazide, DRUGS, 57(5), 1999, pp. 751-755
Risultati: 1-25 | 26-29